New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A new study found a link between SGLT-2 inhibitors and a significantly lower risk of dementia in people with diabetes. Here's ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

There has been a lot of chatter over the past year about the positive impacts of diabetes medications—like Ozempic ... on the gold standard treatment list for congestive heart failure, too ...

The data includes approximately 300,000 adults aged 18–84 who started treatment with either GLP-1 analogs or SGLT2 inhibitors, another type of diabetes medication, during the years 2013–2021.

Your donation makes it possible for us to keep doing this important work, keeping you informed every step of the way to the November election Medication used to treat type 2 diabetes has been ...

ScienceDaily: Some Diabetes Drugs Tied To Lower Risk Of Dementia, Parkinson's Disease A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, ...

Accessed 9/7/2023. . With this statistic in mind, it’s no surprise that many people are curious about Ozempic, an injectable treatment for diabetes ... proposed list of drugs to renegotiate ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Minneapolis: According to a study, a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson's disease. The findings were published in the online edition of ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...